JP2005530822A5 - - Google Patents

Download PDF

Info

Publication number
JP2005530822A5
JP2005530822A5 JP2004512710A JP2004512710A JP2005530822A5 JP 2005530822 A5 JP2005530822 A5 JP 2005530822A5 JP 2004512710 A JP2004512710 A JP 2004512710A JP 2004512710 A JP2004512710 A JP 2004512710A JP 2005530822 A5 JP2005530822 A5 JP 2005530822A5
Authority
JP
Japan
Prior art keywords
mass
suspension
approximately
active ingredient
vehicle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004512710A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005530822A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/018922 external-priority patent/WO2003105804A1/en
Publication of JP2005530822A publication Critical patent/JP2005530822A/ja
Publication of JP2005530822A5 publication Critical patent/JP2005530822A5/ja
Pending legal-status Critical Current

Links

JP2004512710A 2002-06-17 2003-06-17 イブプロフェン懸濁液 Pending JP2005530822A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38873402P 2002-06-17 2002-06-17
PCT/US2003/018922 WO2003105804A1 (en) 2002-06-17 2003-06-17 Ibuprofen suspension

Publications (2)

Publication Number Publication Date
JP2005530822A JP2005530822A (ja) 2005-10-13
JP2005530822A5 true JP2005530822A5 (enExample) 2006-08-03

Family

ID=29736532

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004512710A Pending JP2005530822A (ja) 2002-06-17 2003-06-17 イブプロフェン懸濁液

Country Status (10)

Country Link
US (1) US20040258716A1 (enExample)
EP (1) EP1513499B1 (enExample)
JP (1) JP2005530822A (enExample)
CN (2) CN101862292A (enExample)
AT (1) ATE541562T1 (enExample)
AU (1) AU2003238221A1 (enExample)
CA (1) CA2486553C (enExample)
ES (1) ES2379464T3 (enExample)
IL (1) IL165786A0 (enExample)
WO (1) WO2003105804A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005076829A2 (en) * 2004-02-05 2005-08-25 Taro Pharmaceuticals U.S.A., Inc. Stable loratadine spill resistant formulation
US20050266031A1 (en) * 2004-05-25 2005-12-01 Jay Dickerson Pharmaceutical suspension composition
US8021682B2 (en) * 2004-08-13 2011-09-20 Gallipot, Inc. Palatable suspending vehicle for pharmaceutical ingredients
US7799331B2 (en) 2005-08-04 2010-09-21 Taro Pharmaceutical North America, Inc. Oral suspension of prednisolone acetate
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
CA2641450A1 (en) * 2006-02-06 2007-08-16 Taro Pharmaceuticals North America, Inc. Spill resistant antibiotic formulations
WO2007117605A2 (en) * 2006-04-06 2007-10-18 Taro Pharmaceuticals North America, Inc. Novel spill-resistant formulations comprising hydrocolloidal polymers
CN101472676B (zh) * 2006-04-20 2013-09-11 万罗赛斯公司 利用微通道工艺技术处理和/或形成一种非牛顿流体的方法
GB2438287A (en) * 2006-05-19 2007-11-21 Norbrook Lab Ltd Stable aqueous suspension
FR2922443B1 (fr) * 2007-10-17 2012-11-09 Georgia Pacific France Composition cosmetique destinee a impregner un article de nettoyage et/ou de soin de la peau
CA2705681C (en) 2007-11-13 2013-06-18 Meritage Pharma, Inc. Corticosteroid compositions
CA2726726A1 (en) * 2008-09-10 2010-03-18 Thrubit B.V. Ibuprofen for topical administration
EP2207536A1 (en) 2008-09-22 2010-07-21 BioChemics, Inc. Transdermal drug delivery using an osmolyte and vasoactive agent
TW201038296A (en) * 2009-04-27 2010-11-01 Aplicaciones Farmacodinamicas S A Lab De Ibuprofen lysinate oral suspension
EP2440210A4 (en) 2009-06-12 2014-01-29 Meritage Pharma Inc METHOD FOR THE TREATMENT OF STOMACH DARM DISEASES
KR101683293B1 (ko) * 2009-06-29 2016-12-06 라이온 가부시키가이샤 경구용 조성물
AR078283A1 (es) * 2009-09-10 2011-10-26 Bial Portela & Ca Sa Formulaciones de suspension oral de dibenzazepina carboxamidas
US20140080912A1 (en) * 2012-09-18 2014-03-20 Mcneil-Ppc, Inc. Suspension Pharmaceutical Formulations Comprising Low Melting Propionic Acid Derivative Particles
JP6221644B2 (ja) * 2012-11-09 2017-11-01 大正製薬株式会社 経口用組成物
WO2015155703A2 (en) 2014-04-09 2015-10-15 Nanoceutica Laboratories Pvt. Ltd Composition and method of producing nanoformulation of water insoluble bioactives in aqueous base
US20160346300A1 (en) * 2015-05-29 2016-12-01 Kiel Laboratories, Inc. Liquid formulations of celecoxib for oral administration
CN106397181B (zh) * 2016-09-08 2019-01-01 山东理工大学 一种通过添加十二烷基硫酸钠自水溶液中制备长针状布洛芬晶体的方法
US20180078516A1 (en) * 2016-09-19 2018-03-22 Innovazone Labs LLC Pharmaceutical Composition of Ibuprofen Sodium for Oral Administration
US20240000734A1 (en) * 2020-12-04 2024-01-04 Laboratorios Silanes S.A. De C.V. Pharmaceutical composition having an analgaesic and an antihistamine for treating respiratory diseases

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2921884A (en) * 1957-09-30 1960-01-19 Sterling Drug Inc Pharmaceutical compositions
JPS5831210B2 (ja) * 1973-04-09 1983-07-05 武田薬品工業株式会社 アンテイナスイセイケンダクエキノセイゾウホウ
US4361580A (en) * 1980-06-20 1982-11-30 The Upjohn Manufacturing Company Aluminum ibuprofen pharmaceutical suspensions
US4427681A (en) * 1982-09-16 1984-01-24 Richardson-Vicks, Inc. Thixotropic compositions easily convertible to pourable liquids
DE3532562A1 (de) * 1985-09-12 1987-03-12 Dolorgiet Gmbh & Co Kg Transdermal resorbierbare, wasserhaltige zubereitungen von arylpropionsaeurederivaten und verfahren zur herstellung derselben
US4684666A (en) * 1986-08-19 1987-08-04 Haas Pharmaceuticals, Inc. Stabilized liquid analgesic compositions
JPS63218247A (ja) * 1987-03-06 1988-09-12 Yoshiaki Kawashima 高機能懸濁液
US4788220A (en) * 1987-07-08 1988-11-29 American Home Products Corporation (Del.) Pediatric ibuprofen compositions
US4956184A (en) * 1988-05-06 1990-09-11 Alcide Corporation Topical treatment of genital herpes lesions
US5006360B1 (en) * 1988-06-27 1992-04-28 Low calorie fat substitute compositions resistant to laxative side effect
US4918103A (en) * 1988-07-25 1990-04-17 Formulations Development Labs Liquid oral pharmaceutical compositions of non-steroidal anti-inflammatory drugs
US4883660A (en) * 1988-10-17 1989-11-28 Thames Pharmacal Co., Inc. Gel bases for pharmaceutical compositions
US4975465A (en) * 1989-03-28 1990-12-04 American Home Products Corporation Orally administrable ibuprofen compositions
NZ234143A (en) * 1989-06-28 1991-10-25 Mcneil Ppc Inc Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents
JPH0714872B2 (ja) * 1990-02-06 1995-02-22 昭和薬品化工株式会社 シロップ剤組成物
JP2814138B2 (ja) * 1990-07-23 1998-10-22 エスエス製薬株式会社 懸濁シロップ剤
DE69131200T2 (de) * 1990-08-02 1999-12-09 Chiron Corp., Emeryville Herpes simplex virus vp16 impfstoffe
US5137183A (en) * 1990-08-02 1992-08-11 Mikulec Timothy L Compressible feeding apparatus
US5300302A (en) * 1990-10-04 1994-04-05 Nestec S.A. Pharmaceutical composition in gel form in a dispensing package
US5881926A (en) * 1993-03-11 1999-03-16 Taro Pharmaceutical Industries, Ltd. Pharmaceutical compositions in semisolid form and a device for administration thereof
IL108366A (en) * 1993-03-11 1999-11-30 Taro Vit Ind Ltd Semi-solid pharmaceutical compounds and a device for their use
IT1264857B1 (it) * 1993-06-21 1996-10-17 Zambon Spa Composizione farmaceutica liquida per uso orale contenente acido 2-(4-isobutilfenil) propionico
FR2713931B1 (fr) * 1993-12-20 1996-04-05 Laurence Paris Nouvelles compositions pharmaceutiques liquides à base d'ibuprofène et leur procédé de préparation.
US5563177A (en) * 1995-01-30 1996-10-08 American Home Products Corporation Taste masking guaifenesin containing liquids
JPH08333245A (ja) * 1995-06-07 1996-12-17 Taisho Pharmaceut Co Ltd イブプロフェン懸濁液剤
CN1220598A (zh) * 1996-05-02 1999-06-23 大正制药株式会社 水难溶性酸性药物的悬浮液
US5712310A (en) * 1996-06-14 1998-01-27 Alpharma Uspd, Inc. Suspension of substantially water-insoluble drugs and methods of their manufacture
GB2318511A (en) * 1996-10-23 1998-04-29 Eurand Int Process for the preparation of a pharmaceutical composition for rapid suspension in water
AU6855198A (en) * 1997-04-21 1998-11-13 Taisho Pharmaceutical Co., Ltd. Ibuprofen suspension preparations
US5840768A (en) * 1997-06-04 1998-11-24 Fmc Corporation MCC: alginate pharmaceutical suspensions
US6071523A (en) * 1998-06-03 2000-06-06 Taro Pharmaceuticals Industries, Ltd. Spill resistant pharmaceutical compositions in semi-solid form
US6190701B1 (en) * 1999-03-17 2001-02-20 Peter M. Ronai Composition and method for stable injectable liquids
ES2234581T3 (es) * 1999-04-06 2005-07-01 Ethypharm Suspension farmaceutica bebible de ibuprofeno.
US6557732B2 (en) * 2000-07-19 2003-05-06 The Procter & Gamble Company Detergent pack
JP2001294528A (ja) * 2001-06-06 2001-10-23 Kobayashi Kako Kk アシクロビル懸濁シロップ剤

Similar Documents

Publication Publication Date Title
JP2005530822A5 (enExample)
CN101141961B (zh) 索非那新或其盐的稳定的颗粒状药物组合物
JP2013014634A (ja) 酢酸プレドニゾロンの経口懸濁液
JP2012121912A (ja) 水性懸濁液剤
DE10254412A1 (de) Arzneimittel
CN101848699A (zh) 稳定的卡立氨酯儿科混悬剂
CA2867236A1 (en) Organic compound nano-powder, method for producing the same and suspension
CN101778626A (zh) 含有瑞巴派特的药物组合物
BRPI0720118B1 (pt) forma sólida de dosagem farmacêutica para administração oral compreendendo cloridrato de valganciclovir
CA2486553A1 (en) Ibuprofen suspension
DE102005026755A1 (de) Herstellung von festen Lösungen schwerlöslicher Wirkstoffe durch Kurzzeitüberhitzung und schnelle Trocknung
JP2022031345A (ja) Ｓｔ－２４６（テコビリマット一水和物）懸濁製剤
ES2204517T3 (es) Composiciones de capsula farmaceutica que contienen loratadina y pseudoefedrina.
CN1142182A (zh) 含有一种泡腾系统和一种活性药用物质的粒状产品或片剂以及一种用于其制备的方法
EP2005945A2 (en) Oseltamivir phosphate granule and preparation mehtod thereof
WO2004087111A1 (en) Oral taste masked pharmaceutical compositions
CN101909602B (zh) 口服粉粒状抗肿瘤剂
US4837211A (en) Spironolactone composition
CN104254249B (zh) 帕唑帕尼制剂
AU776587B2 (en) Ciclesonide-containing aqueous pharmaceutical composition
KR101595107B1 (ko) 플라보이드 분획 및 잔탄 검을 포함하는 경구 현탁액 형태의 약학 조성물
JP2018083809A (ja) シロドシン含有粒子の製造方法及びシロドシン含有口腔内崩壊錠の製造方法
JP6186139B2 (ja) 口腔内速崩壊性錠剤
KR102021149B1 (ko) 정제 및 그 제조 방법
AU2001283191A1 (en) Compositions containing an inhibitor of dihydrofolate reductase and a folate